Electrochemistry of electroless plating

I Ohno - Materials Science and Engineering: A, 1991 - Elsevier
The present review describes the electrochemical aspects of electroless plating in four
sections:(1) electrochemical polarization behaviours;(2) catalytic aspects of electroless …

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind …

AX Zhu, YK Kang, CJ Yen, RS Finn, PR Galle… - The lancet …, 2019 - thelancet.com
Background Patients with advanced hepatocellular carcinoma and increased α-fetoprotein
concentrations have poor prognosis. We aimed to establish the efficacy of ramucirumab in …

Anodic oxidation of reductants in electroless plating

I Ohno, O Wakabayashi… - Journal of the …, 1985 - iopscience.iop.org
The anodic oxidation of reductants (hypophosphite, formaldehyde, borohydride,
dimethylamine borane, and hydrazine) was studied on different metal electrodes (Au, Pt, Pd …

Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised …

M Ueno, M Ikeda, C Morizane, S Kobayashi… - The lancet …, 2019 - thelancet.com
Background This study aimed to assess the safety and tolerability of the immune checkpoint
inhibitor nivolumab, as monotherapy or combined with chemotherapy, in Japanese patients …

[HTML][HTML] Systemic chemotherapy for advanced hepatocellular carcinoma: past, present, and future

M Ikeda, S Mitsunaga, I Ohno, Y Hashimoto… - Diseases, 2015 - mdpi.com
Systemic chemotherapy is one of the most important treatment modalities for advanced
hepatocellular carcinoma (HCC). Before the introduction of sorafenib, cytotoxic agents …

[HTML][HTML] Ellagic acid induces apoptosis through inhibition of nuclear factor κB in pancreatic cancer cells

M Edderkaoui, I Odinokova, I Ohno… - World Journal of …, 2008 - ncbi.nlm.nih.gov
AIM: To determine the effect of ellagic acid on apop-tosis and proliferation in pancreatic
cancer cells and to determine the mechanism of the pro-survival effects of ellagic acid …

NADPH oxidase promotes pancreatic cancer cell survival via inhibiting JAK2 dephosphorylation by tyrosine phosphatases

JK Lee, M Edderkaoui, P Truong, I Ohno, KT Jang… - Gastroenterology, 2007 - Elsevier
Background & Aims: Growth factors, such as insulin-like growth factor-1 (IGF-I), protect
pancreatic cancer (PaCa) cells from death. We recently showed that reactive oxygen …

REACH-2: A randomized, double-blind, placebo-controlled phase 3 study of ramucirumab versus placebo as second-line treatment in patients with advanced …

AX Zhu, YK Kang, CJ Yen, RS Finn, PR Galle… - 2018 - ascopubs.org
4003 Background: Patients (pts) with advanced HCC and elevated AFP have a poorer
prognosis compared to the general HCC population, and need effective, well tolerated …

Characterization of patients with advanced pancreatic cancer and high serum interleukin-6 levels

T Miura, S Mitsunaga, M Ikeda, S Shimizu, I Ohno… - Pancreas, 2015 - journals.lww.com
Objectives High serum level of interleukin 6 (IL-6) is associated with high degree of tumor
progression and systemic weakness. Anti–IL-6 therapy possibly improves the deterioration …

[HTML][HTML] Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab

AX Zhu, RS Finn, YK Kang, CJ Yen, PR Galle… - British journal of …, 2021 - nature.com
Background Post hoc analyses assessed the prognostic and predictive value of baseline
alpha-fetoprotein (AFP), as well as clinical outcomes by AFP response or progression …